Although no one pathway was significantly enriched in the variant TP53 cohort over the wildtype cohort, KRAS signaling downregulation approached significance (freq = 15%; FDR = 0.09; Supplementary Fig.
← all excerpts
Multiple Germline Events Contribute to Cancer Development in Patients with Li-Fraumeni Syndrome.
1
—
—